Newsroom – Insights, 
Announcements & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates, 
speaking engagements, and media appearances.

Newsroom – Insights,
Events & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates, 
speaking engagements, and media appearances.

Cyntegrity logo – Risk-Based Quality Management Solutions

Upcoming Events

Stay up to date with upcoming events, including new training sessions, webinars and workshops.

27 April 2026

Xtalks Webinar: Designing Risk-Based QA Oversight for Clinical Trials (ICH E6 R3) | Cyntegrity – ADAMAS – Xtalks
Register for free here… 

29 April 2026

actON QbD webinar | “Vendor oversight & RBQM – What’s the connection?” with RBQM SME Keith Dorricott, MBB, and Cyntegrity’s Head of Growth, Julien Goncalves.
Register for free here…

20 May 2026

mindsON RBQM webinar | “Managing risks across multiple trials” with Cyntegrity’s Chief Scientific OfficerDr. Johann Proeve, and  RBQM SME Keith Dorricott, MBB.
Register for free here…

Tamara Beck, Marketing Operations Manager at Cyntegrity

Tamara Beck

Operations Manager, MyRBQM® Academy & Event Coordinator

Get in touch with Tamara for event details, co-speaking opportunities, or to connect with our alumni community.

Email

academy@cyntegrity.com

Phone Number

+49 (0) 6192 470 113 50

Website

academy.cyntegrity.com

Stay Informed with Us

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What clinical trial teams must understand to stay inspection-ready....

Global Uncertainty and Clinical Research: Why a Risk-Based Perspective Matters

Global risks in clinical trials are increasing as geopolitical instability, supply chain disruptions, and regulatory changes affect research worldwide. Learn why RBQM is essential for proactive oversight....
It seems we can’t find what you’re looking for.

Article Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip …

The Real Cost of Trial Delays & How RBQM Reduces Risk

Clinical trial delays are costly. Learn updated cost estimates and how RBQM + QbD make studies more predictable, efficient, and patient-focused.

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

AI Use in Clinical Trials Is Increasing.
So Are Expectations.

Regulators expect controlled, documented use of AI. Equip your teams to apply AI within GCP, without introducing compliance risk.